The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence
This project will evaluate the effect of a single sub-anesthetic dose of ketamine on the time to first cocaine use and abstinence rates in 60 treatment-seeking cocaine-dependent individuals receiving mindfulness-based relapse prevention (MBRP) therapy, using a 5 week combined laboratory-inpatient and outpatient double-blind, randomized, controlled trial.
Study Arms & Interventions
Ketamine
experimentalA single 40-minute intravenous infusion of ketamine (0.5 mg/kg) combined with a 5-week course of mindfulness-based relapse prevention (MBRP).
Interventions
- Ketamine0.5 mg/kgvia IV• single dose• 1 doses total
40-minute slow-drip infusion; combined with MBRP
Midazolam
active comparatorA single 40-minute intravenous infusion of midazolam (0.025 mg/kg) combined with a 5-week course of mindfulness-based relapse prevention (MBRP).
Interventions
- Placebo0.025 mg/kgvia IV• single dose• 1 doses total
40-minute slow-drip infusion; used as active control; combined with MBRP
Study Details
- StatusTerminated
- PhasePhase IPhase II
- Typeinterventional
- DesignRandomizedquadruple Blind
- Target Enrollment55 participants
- TimelineStart: 2012-02-01End: 2017-04-01
- Compounds
Study Team
Sponsors & Collaborators
- New York State Psychiatric InstitutePrimary Sponsor